A Phase Ib/II, multi-center, open-label study to evaluate the efficacy of AUY922 in combination with Trastuzumab in patients with locally advanced or metastatic HER 2-positive breast cancer, that has progressed after or during at least one

  • Rea, Daniel (Principal Investigator)

Project Details

Short titleA Phase Ib/II, multi-center, open-label study to evaluate the efficacy of AUY922 in combination with Trastuzumab in patients with locally advanced or metastatic HER 2-positive breast cancer, that has progressed after or during at least one
StatusFinished
Effective start/end date1/02/11 → 31/01/15

Funding

  • Queen Elizabeth Hospital Birmingham